Author

Hongyu Su

Nankai UniversityPrimary ORCID profile (0000-0002-4879-2575 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Hongyu SuiD1 paper · University of Michigan

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:scATAC-seq· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Allison C. FergusoniD· 1 shared Clayton J. HabigeriD· 1 shared David A. HanaueriD· 1 shared David Wu· 1 shared Heyang HuaiD· 1 shared Jacqueline K. Lee· 1 shared Jason C. RechiD· 1 shared Jenny Xun· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Allison C. FergusonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CSFeatures improves identification of cell type-specific differential features in single-cell and spatial omics data

Rufeng Li, Yongkang Li, Heyang Hua, Zhen Li, Hongyu Su, Yu Zhang, Yufei Yao, Yidong Wang, Shengquan Chen, Yungang Xu

CSFeatures identifies cell type-specific differential features in single-cell and spatial omics data by considering expression levels, smoothness, and proportion across cell populations.

Journal of Advanced Research · May 1, 2026Peer-reviewedBioinformatics

FDA-approved drug repurposing in zebrafish identifies thyroid hormone and other compounds as potential antithrombotics

Murat Yaman, Hongyu Su, Jacqueline K. Lee, Allison C. Ferguson, Katherine M Sowell, Jenny Xun, David Wu, Clayton J. Habiger, David A. Hanauer, Martin C. Clasby, Jason C. Rech, Jordan A. Shavit

This study uses zebrafish to screen FDA-approved drugs for antithrombotic effects, identifying thyroid hormone and others as potential treatments for VTE subtypes.

bioRxiv · Sep 23, 2025 · PreprintPharmacology & Toxicology